Skip to main content

Roser Solans Laque

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Roser Solans Laque

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Spanish Registry of patients with Systemic vasculitides (REVAS).

This is a multicentre study supported by the Systemic Autoimmune Diseases Group (GEAS) from the Spanish Internal Medicine Society (SEMI). The aim of the study is to describe the different clinical forms of presentation of these diseases, the response to the conventional treatment of the different subtypes of vasculitides, and the prognostic factors and survival in our country. This study includes 17 Hospitals from Spain with a cohort of 300 patients. We are the study coordinator Centre.

IP: Roser Solans Laque

Cardiac involvement in Churg-Strauss Granulomatosis (EGPE).

Cardiac involvement is one of the most important causes of dead in EGPE. The aim of this study is to investigate the prevalence of silent cardiac involvement in patients with EGPE, and if some chemotaxins (eotaxins 1, 2 and 3) may play a key role in its development, in order to establish an early tretament.

IP: Roser Solans Laque

Risk factors for ischemic events in biopsy-proven Giant Cell Arteritis (GCA).

The study aims to investigate the risk factors for ischemic complications in patients with GCA, and the role that some endothelial growth factors may play in its development. This study is coordinated by Dr. Gonzalez Gay from University Hospital of Valdecilla, Santander.

IP: Roser Solans Laque

International Classification Criteria project for neuro-Behçet disease.

We are currently enrolled in this multicentre study coordinated by Dr. Seema Kalra from University Hospital of North Staffordshire (UK). The study aims to define new diagnostic criteria for neuro-Behçet disease. A set of neurologists, rheumatologists and specialists in Internal Medicine from different countries, experts in the diagnosis and management of this disease, will try to define a new set of diagnostic criteria based on clinical expertise, and in the most new laboratory and radiology modern tests.

IP: Roser Solans Laque

Projects

Autoimmunitat i malaltia trombòtica

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 49920
Reference: 2009 SGR 661
Duration: 01/01/2010 - 30/04/2014

Autoimmunitat i malaltia trombòtica

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Antonio San Jose Laporte, Vicenç Fonollosa Pla, José Ordi Ros, Albert Selva O'Callaghan, Maria Urquizu Padilla
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2005SGR 00279
Duration: 01/01/2006 - 31/12/2008

Related news

A Vall d’Hebron team demonstrates, for the first time, the potential of optical genome mapping to detect genetic alterations associated with this rare disease that are not identified using conventional methods.

The study describes the first documented case worldwide of hereditary angioedema transmission through assisted reproduction.

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Related professionals

Camilo Andres Bonilla Rojas

Camilo Andres Bonilla Rojas

Shock, Organ Dysfunction and Resuscitation
Read more
Pedro Pablo Jordán Marchite

Pedro Pablo Jordán Marchite

Predoctoral researcher
Cardiovascular Diseases
Read more
Maria Crespi Amer

Maria Crespi Amer

Predoctoral researcher
Clinical Neuroimmunology
Read more
Clara Rey Valenzuela

Clara Rey Valenzuela

Research technician
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.